期刊
DIABETES CARE
卷 36, 期 6, 页码 1729-1731出版社
AMER DIABETES ASSOC
DOI: 10.2337/dc12-1067
关键词
-
资金
- National Science Council grant [NSC98-2314-B-182-009-MY3]
- Chang Gung University [EMRPD1A0851]
- Saint Mary's Hospital Luodong
OBJECTIVE-Metabolic syndrome is a multiplex disorder and puts patients on the road to type 2 diabetes and atherosclerotic cardiovascular diseases. However, a surrogate biomarker in plasma or urine in fully reflecting features of metabolic syndrome has not been explored. RESEARCH DESIGN AND METHODS-Urine metabolomics has potential utility in metabolic profiling because urine metabolites analysis reflects global outflux of metabolic change. Accordingly, we collected data on subjects (n = 99) with overweight, dyslipidemia, hypertension or impaired glucose tolerance and took a metabolomics approach to analyze the metabolites of urine revealed in metabolic syndrome by high-performance liquid chromatography-time-of-flight mass spectrometry and elicit potential biomarkers to picture metabolic syndrome. RESULTS-Our results revealed that the urine nicotinuric acid value of subjects with diabetes (HbA(1c) >= 6.5% or those receiving diabetes medications) (n = 25) was higher than subjects without diabetes (n = 37) (221 +/- 31 vs. 152 +/- 13 X 10(3) mAU, P = 0.0268). Moreover, urinary nicotinuric acid level was positively correlated with body mass index, blood pressure, total cholesterol, low-density lipoprotein cholesterol, triacylglycerol and high sensitivity C-reactive protein, but negatively correlated with high-density lipoprotein cholesterol. CONCLUSIONS-This is the first study, to our knowledge, to propose that nicotinuric acid represents an important pathogenic mechanism in process from metabolic syndrome to diabetes and atherosclerotic cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据